Loading...
Market
What will be the outcome of any internal NIH investigation into the use of private email by Dr. Anthony Fauci by December 31, 2024?
2
Resolution / Starting Odds
No action taken • 25%
Reprimand issued • 25%
Policy change recommended • 25%
Other • 25%
NIH official statements, news reports
Story
Fauci Accused of Using Private Email Amid 'Beaglegate' Controversy with Yasmeen Abutaleb
Jul 30, 2024, 12:47 AM
Dr. Anthony Fauci has been accused of using a private email account to communicate with Washington Post journalist Yasmeen Abutaleb in October 2021 during a public relations crisis over NIH-funded experiments on beagle puppies, referred to as 'Beaglegate.' The experiments, which allegedly tormented and killed the animals, have sparked significant backlash. FOIA records obtained by White Coat Waste and shared with the New York Post reveal that Fauci reached out to the journalist amid the controversy.
View original story
Similar markets
No evidence of censorship • 25%
Some evidence of censorship • 25%
Strong evidence of censorship • 25%
Inconclusive • 25%
Exoneration • 25%
Minor reprimand • 25%
Major reprimand • 25%
Criminal charges • 25%
No censorship found • 25%
Partial censorship found • 25%
Full censorship found • 25%
Inconclusive • 25%
Exoneration of Fauci and NIH • 25%
Criticism without legal action • 25%
Legal action recommended • 25%
Investigation inconclusive • 25%
No action taken • 25%
Formal apology issued • 25%
Reprimands issued • 25%
Policy changes implemented • 25%
Yes • 50%
No • 50%
Complete exoneration • 25%
Partial exoneration • 25%
Complete misconduct confirmation • 25%
Inconclusive findings • 25%
New revelations • 25%
No significant findings • 25%
Investigation not conducted • 25%
Other outcome • 25%
Conviction • 25%
Acquittal • 25%
Case Dismissed • 25%
No Proceedings • 25%
Samples found intact • 25%
Samples found compromised • 25%
Samples not found • 25%
Investigation inconclusive • 25%
No action taken • 25%
Official investigation launched • 25%
HHS issues a formal apology • 25%
Other • 25%
Study published • 25%
NIH takes action • 25%
Congressional hearing held • 25%
No significant outcome • 25%